Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RE-DUAL PCI Real Life Registry in ACS patients undergoing PCI
NL-OMON50081Phase 4Withdrawn
- Sponsor
- Zuyderland
- Start
- Aug 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dabigatran, clopidogrel and aspirin in acute coronary syndrome (ACS) and Atrial fibrillation (AFib) (2 arms), sponsored by Zuyderland. Planned start Aug 2020; status: withdrawn.
02
Drugs
dabigatranclopidogrelaspirin
03
Conditions
acute coronary syndrome (ACS)Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NL-OMON50081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50081.